Scholars Central

Conference abstractPublished 26 Oct 2015

Validating the efficacy of the human embryonic stem cell (hESC) therapy in cerebral palsy patients

Authors: Geeta Shroff

Nutech Mediworld, India

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Introduction: We have previously shown that hESCs have the potential to treat Cerebral Palsy (CP) related neurological impairments. Here, we focus on the validation of efficacy of hESC therapy in patients with CP. Methodology: This was a record based study (October 2007 to July 2013) of 101 CP patients (age<54 years). hESCs were given in four treatment sessions (T1- T4). The variables âÂ?Â?ILLNESSâÂ? and âÂ?Â?EMENDMENTâÂ? were analyzed. Results: Of 101 patients, 73 attended T2, 41 attended T3 and 15 attended T4. For T1, the average duration of therapy (TD 1) was 60 days. At the end of T1, patients had improved by ~180% from baseline. Similarly, for T2, T3 and T4 (TD 2, 3=59 days; TD 4=60 days), an improvement by 162%, 153% and 170%, respectively from end of previous session was noted. During T1, T2, T3 and T4 the âÂ?Â?ILLâÂ? patients, who were âÂ?Â?severeâÂ?Â? (53, 36, 20, and 6) at admission, emended as endured (40, 28, 17 and 5) and profuse (13, 8, 3 and 1) at discharge. Moderate âÂ?Â?ILLâÂ? patients (48, 48, 2 and 9) at admission emended as âÂ?Â?profuseâÂ? (36, 28, 17 and 7) and âÂ?Â?enduredâÂ? (12, 9, 4 and 2) at discharge. For severe cases at admission, the odds of profuse emending when therapy ended were 0.11, 0.09, 0.75 and 0.04 times lower than the cases that were moderate at admission. Conclusion: hESCs therapy caused betterment in the condition of CP patients compared to first admission during each session.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Translational Medicine.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalTranslational Medicine
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Geeta Shroff”